Jiaxi Deng
State Key Laboratory Of Respiratory Disease
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The prognostic impact of severe grade immune checkpoint inhibitor related pneumonitis in non-small cell lung cancer patients.
Journal: Frontiers in oncology
Published: January 18, 2024
Cyclosporine successfully treats steroid-resistant checkpoint inhibitor-related pneumonitis: a case report.
Journal: BMC pulmonary medicine
Published: September 21, 2023
A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case-Control Study.
Journal: Clinical drug investigation
Published: April 04, 2023
Case report: Spontaneous remission in lung carcinoma with a late relapse after adjuvant immunotherapy: Exceptional tumor micro-environment.
Journal: Frontiers in immunology
Published: November 23, 2022
Successful management of Epstein‑Barr virus‑associated severe checkpoint inhibitor‑related pneumonitis: A case report.
Journal: Experimental and therapeutic medicine
Published: September 19, 2022
Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis.
Journal: Frontiers in immunology
Published: November 19, 2021
Identification of the Unique Clinical and Genetic Features of Chinese Lung Cancer Patients With EGFR Germline Mutations in a Large-Scale Retrospective Study.
Journal: Frontiers in oncology
Published: September 11, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026